Patents by Inventor Yanran HE

Yanran HE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer treatment with 237 CAR-T cell based therapeutics recognizing the Tn epitope
    Patent number: 12398192
    Abstract: The disclosure provides Tn epitope-specific chimeric antigen receptors and scFvs, including soluble scFvs and multimeric scFvs, as well as methods of identifying cancer subjects and cancer subject sub-populations amenable to anti-Tn immunotherapy and methods of treating cancer.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: August 26, 2025
    Assignees: The University of Chicago, The Board of Trustees of the University of Illinois
    Inventors: Hans Schreiber, David Kranz, Karin Schreiber, Yanran He, Preeti Sharma
  • CANCER TREATMENT WITH 237 CAR-T CELL BASED THERAPEUTICS RECOGNIZING THE TN EPITOPE
    Publication number: 20220047631
    Abstract: The disclosure provides Tn epitope-specific chimeric antigen receptors and scFvs, including soluble scFvs and multimeric scFvs, as well as methods of identifying cancer subjects and cancer subject sub-populations amenable to anti-Tn immunotherapy and methods of treating cancer.
    Type: Application
    Filed: September 11, 2019
    Publication date: February 17, 2022
    Applicants: The University of Chicago, The Board of Trustees of the University of Illinois
    Inventors: Hans SCHREIBER, David KRANZ, Karin SCHREIBER, Yanran HE, Preeti SHARMA